<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02348944</url>
  </required_header>
  <id_info>
    <org_study_id>COVAR</org_study_id>
    <nct_id>NCT02348944</nct_id>
  </id_info>
  <brief_title>Biological Variability in Cartilage Specific Biomarkers in Healthy Volunteers.</brief_title>
  <acronym>COVAR</acronym>
  <official_title>Evaluation of Biological Variability in Cartilage Specific Biomarkers (Coll2-1, Coll2-1NO2, FIB3-1 and FIB 3-2) in Healthy Volunteers.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Artialis</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Artialis</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purposes of the study are to assess intra individual biological variability of serum and
      urinary cartilage specific biomarkers and define the best standardized conditions for blood
      and urine sampling in the frame of biomarkers dosage.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To assess intra individual biological variability of serum and urinary cartilage specific
      biomarkers and define the best standardized conditions for blood and urine sampling in the
      frame of biomarkers dosage. Variation factors assessed are:

        -  Fasting condition

        -  Sampling time

        -  Sampling season

        -  Physical activity

        -  Duration and temperature of total blood treatment

        -  Type of blood collection tube.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2013</start_date>
  <completion_date type="Actual">December 2014</completion_date>
  <primary_completion_date type="Actual">December 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
  </study_design_info>
  <primary_outcome>
    <measure>Variation of serum and urine sample between baseline, weeks 2, 16, 52 and 68 to assess intra-individual biological variability of cartilage-specific biomarkers Coll2-1/Coll2-1NO2 / FIB3-1 and FIB3-2.</measure>
    <time_frame>Baseline and weeks 2, 16, 52 and 68</time_frame>
    <description>Change from baseline will be assess by biomarkers dosage using ELISA (Enzyme Linked ImmunoAssay)</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">15</enrollment>
  <condition>Effects of; Serum</condition>
  <condition>Urine Marking</condition>
  <arm_group>
    <arm_group_label>15 healthy volunteers</arm_group_label>
    <description>Other: serum and urine sample</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>serum and urine sample</intervention_name>
    <description>Serum and urine samples will be collected at baseline, weeks2, 16, 52 and 68 to assess intra-individual biological variability of cartilage-specific biomarkers Coll2-1/Coll2-1NO2 / FIB3-1 and FIB3-2.</description>
    <arm_group_label>15 healthy volunteers</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Serum and urine samples
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Male or female above 18 years
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male or female, aged above 18 years.

          -  Sign an informed consent after being informed

          -  Able to follow the instructions of the study

        Exclusion Criteria:

          -  Serious associated diseases:

               -  Severe liver disease

               -  Renal failure

               -  HIV

               -  hepatitis B or C

          -  Patient who are the subject of a judicial protection measure or under guardianship
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bernard Jandrain, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Clinical Pharmacology Unit, ATC sa, Belgium</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>ATC SA, Unit√© de pharmacologie clinique, CHU Sart Tilman</name>
      <address>
        <city>Liege</city>
        <zip>4000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>January 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 19, 2015</study_first_submitted>
  <study_first_submitted_qc>January 23, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 28, 2015</study_first_posted>
  <last_update_submitted>January 23, 2015</last_update_submitted>
  <last_update_submitted_qc>January 23, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 28, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Biological markers</keyword>
  <keyword>Cartilage</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

